Work

Optimal dose and duration of venetoclax for induction therapy in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-2831

Authors: Mamoon Ahmed, Farooq Ashraf, Anas Al-sadi, Muhammad Shaheer Mannan, Jehad Zeidalkilani, Hafsa Shahid, Aniqa Faraz, Maheen Zahid, Aman Ullah, Sohaib Irfan, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Institutions: Sanford Health, Gujranwala Medical College, University of Missouri–Kansas City, Marshfield Clinic, Marshfield Clinic, Mercy Medical Center Sioux City, Brigham and Women's Hospital, Cumberland Medical Center, Liaquat University of Medical & Health Sciences, Saint Louis University Hospital, Aga Khan University, University of Kansas Medical Center, Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417007226

Cites:

Cited by:

Related to: